# EDGAR Filing Document

**Accession Number:** 0001910456
**File Stem:** 0001910456-25-000004
**Filing Date:** 2025-8
**Character Count:** 16487
**Document Hash:** fabaaf165018e28d9d35b1e5b1ece317
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001910456-25-000004.hdr.sgml**: 20250821

**ACCESSION NUMBER**: 0001910456-25-000004

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250821

**EFFECTIVENESS DATE**: 20250821

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Lynx1 Capital Management LP
- **CENTRAL INDEX KEY:** 0001910456

**ORGANIZATION NAME:**
- **EIN:** 851134656
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231
- **LEGAL ENTITY IDENTIFIER:** 5493003YH8Q5SHT17216

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-22151
- **FILM NUMBER:** 251241650

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** D81 CALLE C
- **STREET 2:** SUITE 301 PMB 1202
- **CITY:** DORADO
- **PROVINCE COUNTRY:** PR
- **ZIP:** 00646
- **BUSINESS PHONE:** 703-963-7214

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** D81 CALLE C
- **STREET 2:** SUITE 301 PMB 1202
- **CITY:** DORADO
- **PROVINCE COUNTRY:** PR
- **ZIP:** 00646

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001910456

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Lynx1 Capital Management LP

**Address:** D81 Calle C, Dorado, PR 00646-2051

**Telephone number:** 7039637214

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-22145

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** 5493003YH8Q5SHT17216

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                 | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                         | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| ALLOGENE THERAPEUTICS, INC.    | 019770106 | 06/18/2025     | TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT.                                                                       | SECTION 14A SAY-ON-PAY VOTES |       11057009 |                0 | FOR         |                                 11057009 | FOR                         |  |
| STOKE THERAPEUTICS, INC.       | 86150R107 | 06/03/2025     | TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |        4603233 |                0 | FOR         |                                  4603233 | FOR                         |  |
| STOKE THERAPEUTICS, INC.       | 86150R107 | 06/03/2025     | TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF FUTURE STOCKHOLDER ADVISORY VOTES TO APPROVE THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.                                   | SECTION 14A SAY-ON-PAY VOTES |        4603233 |                0 | 1 YEAR      |                                  4603233 | FOR                         |  |
| VOYAGER THERAPEUTICS, INC.     | 92915B106 | 06/03/2025     | TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |           1000 |                0 | FOR         |                                     1000 | FOR                         |  |
| ASSEMBLY BIOSCIENCES, INC.     | 045396207 | 06/05/2025     | APPROVAL, ON A NON-BINDING ADVISORY BASIS, OF OUR NAMED EXECUTIVE OFFICERS' COMPENSATION.                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |           7638 |                0 | FOR         |                                     7638 | FOR                         |  |
| IONIS PHARMACEUTICALS, INC.    | 462222100 | 06/05/2025     | TO MAKE AN ADVISORY VOTE ON EXECUTIVE COMPENSATION.                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |             50 |                0 | AGAINST     |                                       50 | AGAINST                     |  |
| RELAY THERAPEUTICS, INC.       | 75943R102 | 06/06/2025     | TO CONSIDER AND ACT UPON AN ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |           1000 |                0 | AGAINST     |                                     1000 | AGAINST                     |  |
| TECTONIC THERAPEUTIC, INC      | 878972108 | 06/06/2025     | ADVISORY APPROVAL OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |            629 |                0 | FOR         |                                      629 | FOR                         |  |
| TECTONIC THERAPEUTIC, INC      | 878972108 | 06/06/2025     | ADVISORY VOTE ON THE FREQUENCY OF STOCKHOLDER ADVISORY VOTES ON EXECUTIVE COMPENSATION.                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |            629 |                0 | 1 YEAR      |                                      629 | FOR                         |  |
| ALX ONCOLOGY HOLDINGS INC      | 00166B105 | 06/11/2025     | ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION.                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |           8491 |                0 | FOR         |                                     8491 | FOR                         |  |
| ALX ONCOLOGY HOLDINGS INC.     | 00166B105 | 06/11/2025     | ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION.                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |           8491 |                0 | FOR         |                                     8491 | FOR                         |  |
| KORRO BIO, INC.                | 500946108 | 06/11/2025     | NON-BINDING ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |           1500 |                0 | FOR         |                                     1500 | FOR                         |  |
| KORRO BIO, INC.                | 500946108 | 06/11/2025     | NON-BINDING ADVISORY VOTE ON THE FREQUENCY OF FUTURE NON-BINDING ADVISORY VOTES TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS                                                              | SECTION 14A SAY-ON-PAY VOTES |           1500 |                0 | 1 YEAR      |                                     1500 | FOR                         |  |
| CULLINAN THERAPEUTICS, INC.    | 230031106 | 06/12/2025     | PROPOSAL TO VOTE, ON AN ADVISORY BASIS, TO APPROVE OUR NAMED EXECUTIVE OFFICER COMPENSATION.                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |        3339816 |                0 | FOR         |                                  3339816 | FOR                         |  |
| CULLINAN THERAPEUTICS, INC.    | 230031106 | 06/12/2025     | PROPOSAL TO VOTE, ON AN ADVISORY BASIS, ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON OUR NAMED EXECUTIVE OFFICER COMPENSATION.                                                                           | SECTION 14A SAY-ON-PAY VOTES |        3339816 |                0 | 1 YEAR      |                                  3339816 | FOR                         |  |
| XENCOR, INC.                   | 98401F105 | 06/12/2025     | TO APPROVE, ON AN ADVISORY (NON-BINDING) BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE ACCOMPANYING PROXY STATEMENT.                                            | SECTION 14A SAY-ON-PAY VOTES |            880 |                0 | FOR         |                                      880 | FOR                         |  |
| C4 THERAPEUTICS, INC.          | 12529R107 | 06/18/2025     | TO CAST A NON-BINDING, ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |        7098133 |                0 | FOR         |                                  7098133 | FOR                         |  |
| PROTAGONIST THERAPEUTICS, INC. | 74366E102 | 06/20/2025     | TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         733014 |                0 | FOR         |                                   733014 | FOR                         |  |
| ADDEX THERAPEUTICS             | 00654J206 | 06/24/2025     | COMPENSATION OF THE MEMBERS OF THE EXECUTIVE MANAGEMENT                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |            125 |                0 | FOR         |                                      125 | FOR                         |  |
| IDEAYA BIOSCIENCES, INC.       | 45166A102 | 06/24/2025     | TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT ACCOMPANYING THIS NOTICE OF ANNUAL MEETING OF STOCKHOLDERS. | SECTION 14A SAY-ON-PAY VOTES |           1000 |                0 | AGAINST     |                                     1000 | AGAINST                     |  |
| KYMERA THERAPEUTICS, INC.      | 501575104 | 06/25/2025     | TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |            500 |                0 | FOR         |                                      500 | FOR                         |  |
| ULTRAGENYX PHARMACEUTICAL INC. | 90400D108 | 05/15/2025     | ADVISORY (NON-BINDING) VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |            100 |                0 | AGAINST     |                                      100 | AGAINST                     |  |
| MERUS N.V.                     | N5749R100 | 05/21/2025     | APPROVAL, ON AN ADVISORY (NON-BINDING) BASIS, OF THE COMPENSATION OF MERUS N.V.'S NAMED EXECUTIVE OFFICERS.                                                                                              | SECTION 14A SAY-ON-PAY VOTES |        1568841 |                0 | FOR         |                                  1568841 | FOR                         |  |
| PRECISION BIOSCIENCES, INC.    | 74019P207 | 05/28/2025     | APPROVAL, ON AN ADVISORY (NON-BINDING) BASIS, OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS (COMMONLY REFERRED TO AS THE SAY-ON-PAY VOTE).                                                         | SECTION 14A SAY-ON-PAY VOTES |         766051 |                0 | FOR         |                                   766051 | FOR                         |  |
| PRECISION BIOSCIENCES, INC.    | 74019P207 | 05/28/2025     | APPROVAL, ON AN ADVISORY (NON-BINDING) BASIS, OF THE FREQUENCY OF FUTURE SAY-ON-PAY VOTES.                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |         766051 |                0 | 1 YEAR      |                                   766051 | FOR                         |  |
| ACADIA PHARMACEUTICALS INC.    | 004225108 | 05/29/2025     | TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT.                                                                       | SECTION 14A SAY-ON-PAY VOTES |            200 |                0 | AGAINST     |                                      200 | AGAINST                     |  |
| PIERIS PHARMACEUTICALS, INC.   | 720795202 | 12/02/2024     | APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT.                                                               | SECTION 14A SAY-ON-PAY VOTES |          36483 |                0 | FOR         |                                    36483 | FOR                         |  |
| ZYMEWORKS INC.                 | 98985Y108 | 12/10/2024     | ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |           9834 |                0 | FOR         |                                     9834 | FOR                         |  |
| VYNE THERAPEUTICS INC.         | 92941V308 | 12/12/2024     | TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE ACCOMPANYING PROXY STATEMENT.                                                          | SECTION 14A SAY-ON-PAY VOTES |          16194 |                0 | FOR         |                                    16194 | FOR                         |  |
| VYNE THERAPEUTICS INC.         | 92941V308 | 12/12/2024     | TO INDICATE, ON AN ADVISORY BASIS, THE FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.                                                                 | SECTION 14A SAY-ON-PAY VOTES |          16194 |                0 | 1 YEAR      |                                    16194 | FOR                         |  |
| IBIO, INC                      | 451033708 | 11/21/2024     | TO APPROVE, ON AN ADVISORY, NON-BINDING BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS (SAY-ON-PAY).                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         262279 |                0 | FOR         |                                   262279 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** Lynx1 Capital Management LP

**By (Signature):** Weston Nichols

**By (Printed Signature):** Weston Nichols

**By (Title):** CFO

**Date:** 08/21/2025